Regulation of ovarian cholesterol esters: evidence for the enzymatic sites of prostaglandin-induced loss of corpus luteum function.
D000818:Animals; D001665:Binding Sites; D002784:Cholesterol / Q000378:metabolism; D003338:Corpus Luteum / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism / Q000502:physiology; D004950:Esterases / Q000502:physiology*; D005260:Female; D007016:Hypophysectomy; D007279:Injections, Subcutaneous; D007986:Luteinizing Hormone / Q000008:administration & dosage / Q000494:pharmacology; D010053:Ovary / Q000187:drug effects / Q000201:enzymology* / Q000502:physiology; D010713:Phosphatidylcholines; D011374:Progesterone / Q000378:metabolism; D011388:Prolactin / Q000008:administration & dosage / Q000494:pharmacology; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D013997:Time Factors; D014166:Transferases / Q000502:physiology*
D010713:Phosphatidylcholines; D011453:Prostaglandins; D011374:Progesterone; D011388:Prolactin; D007986:Luteinizing Hormone; D002784:Cholesterol; D014166:Transferases; D004950:Esterases